| Tolerability of endocrine treatment for advanced breast cancer: results of an international survey. | |
| | |
MedLine Citation:
|
PMID: 9394857 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In contrast with cytotoxic therapy, the impact of hormonal therapy for advanced breast cancer in postmenopausal women is poorly documented. Two recent surveys of the impact of hormonal therapy in this patient group found that side-effects had an adverse impact on patients' quality of life which needed to be taken into account when discussing treatment options. Patients were perceived to be more comfortable discussing treatment-related problems with nurses rather than doctors, who tended to underestimate the distress caused to patients by the side-effects of treatment. A need was identified for better lines of communication between patients and medical professionals, and for a simple, more widely applicable tool for assessment of side-effects. As a result of these findings, a simple checklist, Checklist for Patients on Endocrine Therapy (C-PET), has been developed to be completed by patients before a physician appointment, to form a basis for discussion. A pilot study has indicated that C-PET is easy and quick for patients to complete and aids communication between patients and healthcare professionals. C-PET has now been formally launched to nurses, oncologists, and other cancer physicians. |
| | |
Authors:
|
U Köhler |
Related Documents
:
|
18689857 - Patient-centred information and interventions: tools for lifestyle change? consequences... 17249297 - Vulvar disease update. 7875347 - Consent. 10435357 - Patients' attitude toward consultations by a physician without a white coat in japan. 17690847 - Somatostatin receptor scintigraphy in the follow-up of myasthenia gravis. 22633427 - Symptomatic venous thromboembolism after femoral vein harvest. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Oncology Volume: 54 Suppl 2 ISSN: 0030-2414 ISO Abbreviation: Oncology Publication Date: 1997 |
Date Detail:
|
Created Date: 1998-01-06 Completed Date: 1998-01-06 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0135054 Medline TA: Oncology Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 23-6 Citation Subset: IM |
Affiliation:
|
Department of Gynaecology and Obstetrics, University of Leipzig, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents, Hormonal
/
adverse effects*,
therapeutic use Breast Neoplasms / drug therapy* Europe Female Great Britain Humans International Cooperation Population Surveillance |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents, Hormonal |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal p...
Next Document: The role of selective non-steroidal aromatase inhibitors in future treatment strategies.